MiNK Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 234,182 | $175,637 | 0.00% | 0.59% |
| LONGBOW FINANCE SA | 11/12/2024 | 166,666 | $125,000 | 0.00% | 0.42% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 106,687 | $80,015 | -16.55% | 0.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 97,981 | $73,501 | 1.70% | 0.25% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 88,126 | $66,095 | 100.00% | 0.22% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 51,728 | $36,000 | 2.04% | 0.13% |
| STATE STREET CORP | 11/14/2024 | 25,515 | $19,136 | 0.00% | 0.06% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 15,322 | $11,492 | -57.12% | 0.04% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 11,937 | $8,953 | 100.00% | 0.03% |
| GREENWICH WEALTH MANAGEMENT LLC | 10/29/2024 | 10,805 | $8,000 | 100.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 10,533 | $7,900 | -3.01% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 6,212 | $4,659 | 92.86% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,027 | $3,020 | -54.99% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2,039 | $1,529 | 0.05% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,431 | $1,070 | 0.00% | 0.00% |
| COVESTOR LTD | 11/01/2024 | 1,049 | $1,000 | -0.57% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 336 | $252 | -12.27% | 0.00% |
| CHILTON CAPITAL MANAGEMENT LLC | 11/12/2024 | 309 | $232 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 190 | $143 | 0.00% | 0.00% |
| GAME PLAN FINANCIAL ADVISORS, LLC | 10/15/2024 | 170 | $128 | 0.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 11/13/2024 | 146 | $110 | -2.67% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 129 | $97 | 20.56% | 0.00% |
| KEY FINANCIAL INC | 10/29/2024 | 43 | $32 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 10/23/2024 | 2 | $2 | 0.00% | 0.00% |
| JAFFETILCHIN INVESTMENT PARTNERS, LLC | 11/04/2024 | 1 | $1 | 100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ASSETMARK, INC | 11/01/2024 | 0 | $0 | -100.00% | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 10/04/2024 | 0 | $0 | -100.00% | 0.00% |
| CAMELOT PORTFOLIOS, LLC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
MiNK Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of MiNK Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 234,182
Longbow Finance SA: 166,666
RENAISSANCE TECHNOLOGIES LLC: 106,687
GEODE CAPITAL MANAGEMENT, LLC: 97,981
BlackRock Funding, Inc. /DE: 88,126
HighTower Advisors, LLC: 51,728
2.14% of MiNK Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 925,119 shares in the last 24 months. This purchase volume represents approximately $786,351 in transactions.